1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Pentosan Polysulfate Sodium Market Outlook 2016-2021

Global Pentosan Polysulfate Sodium Market Outlook 2016-2021

  • July 2016
  • -
  • Gen Consulting Company
  • -
  • 93 pages

Pentosan polysulfate sodium is a semi-synthetically produced heparin-like macromolecular carbohydrate derivative, which chemically and structurally resembles glycosaminoglycans. It is a white odorless powder, slightly hygroscopic and soluble in water to 50% at pH 6. Pentosan polysulphate sodium, known also as pentosan polysulphate or PPS, is an organic medicine which is made of a sugar extractedfrom the bark of beech trees. Pentosan polysulphate safely and effectively supports and enhances the body’s defence and repair systems and the growth of new tissue. pentosan polysulphate sodium has an anticoagulant, fibrinolytic and thrombolytic quality with comparatively limited side effects. Pentosan polysulphate sodium is authorised in various countries worldwide for the treatment of an interstitial cystitis, as a supportive therapy for arterial vascular diseases (Claudicatio Intermittens) and as a veterinary medicinal product for osteoarthritic complaints. Used as a veterinary pharmaceutical, pentosan has proven to be an effective treatment for osteoarthritis. Human clinical studies in Australia and Japan suggest benefit in its use as a treatment for osteoarthritis.

Pentosan Polysulfate Sodium production, which measures output worldwide, was expected to reach 10,031 kg in 2016 with an increase of 7.51% from its year-earlier level. The global pentosan polysulfate sodium market size is estimated to grow from USD 42.34 million in 2011 to USD 54.59 million by 2016, at an estimated CAGR of 5.21% between 2011 and 2016. With regards to this, key players of pentosan polysulfate sodium industry are expected to find potential opportunities in this market.

The global pentosan polysulfate sodium market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global pentosan polysulfate sodium market are Janssen Pharmaceutical, Bene Pharmachem, Cf Pharma, Alembic, Parabolic Drugs, etc.

Table Of Contents

Global Pentosan Polysulfate Sodium Market Outlook 2016-2021
Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
1.4 Key Findings
Part 2. Introduction
2.1 Definition
2.2 History
2.3 Medical Uses
2.3.1 Anticoagulant
2.3.2 Interstitial cystitis
2.3.3 Osteoarthritis
2.3.4 Transmissible spongiform encephalopathies
Part 3. Manufacture
3.1 Manufacturing Technologies
Part 4. Value Chain Analysis
4.1 Upstream
4.2 Downstream
4.3 Manufacturing Costs
Part 5. Worldwide Key Vendors
5.1 Janssen Pharmaceutical (USA)
5.2 Bene Pharmachem (Germany)
5.3 Cf Pharma (Hungary)
5.4 Parabolic Drugs (India)
5.5 SWATI SPENTOSE (India)
5.6 Alembic (India)
5.7 WisMed Pharmaceuticals (China)
5.8 Sphinx (China)
Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 China
6.2.2 North America
6.2.3 EMEA
6.2.4 Asia-Pacific
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 China
6.4.2 North America
6.4.3 EMEA
6.4.4 Asia-Pacific
Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 China
7.1.2 North America
7.1.3 EMEA
7.1.4 Asia-Pacific
7.2 Global Consumption by Application
7.3 Chinese Consumption by Application
Part 8. Market Forecast
8.1 Market Size Forecast
8.1.1 China
8.1.2 North America
8.1.3 EMEA
8.1.4 Asia-Pacific
8.2 Regional Consumption Forecast
8.2.1 China
8.2.2 North America
8.2.3 EMEA
8.2.4 Asia-Pacific
8.3 Consumption Forecast by Application
Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Strategies
9.3 Key Events
Part 10. Investment Feasibility
10.1 Global Economic Highlight 2015
10.2 Recent Developments
10.3 The Updated Forecast
10.3.1 Advanced Economies
10.3.2 Emerging Market and Developing Economies
10.4 China Outlook 2016
10.5 Investment in China
10.5.1 Outlook on investment
10.5.2 Growth opportunities
10.5.3 Policy Trends
10.5.4 Conclusions
10.4 Feasibility of New Project
10.4.1 Basis and Presumptions
10.4.2 New Project in China
Abbreviations
Disclaimer
Analyst(s) Certification

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.